Q1 FY 2027 saw robust revenue and EBITDA growth across all segments, with strong execution, higher capacity utilization, and disciplined investments driving profitability. Management reaffirmed full-year guidance and expects margin expansion, especially in CDMO, as overseas utilization improves.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.